24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control, 24-hour blood pressure effect and safety of Latanoprost/Timolol fixed combination given once in the evening with placebo once in the morning versus timolol maleate 0.5% given twice daily in patients with ocular hypertension and primary open-angle glaucoma...
Brief Summary
Official Title: “24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients”
The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control, 24-hour blood pressure effect and safety of Latanoprost/Timolol fixed combination given once in the evening with placebo once in the morning versus timolol maleate 0.5% given twice daily in patients with ocular hypertension and primary open-angle glaucoma.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
- Study Primary Completion Date: April 2007
Intervention(s) in this Clinical Trial
- Drug: timolol maleate 0.5%
- Drug: latanoprost/timolol fixed combination
- Drug: placebo (artificial tears)
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- POAG
- OHT
Exclusion Criteria:
- Advanced glaucoma
- Arterial Hypertension
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 29 Years
Maximum Age for this Clinical Trial: 80 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Aristotle University Of Thessaloniki Other
Overall Clinical Trial Officials and Contacts
AGP Konstas, MD, PhD Principal Investigator Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00330577
Study ID Number: A594
ClinicalTrials.gov Identifier: NCT00330577
Health Authority: Greece: National Organization of Medicines
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00330577
